Marker Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.32

+0.02 (+1.54%)

As of Apr 1, 3:56 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,132.6% upside

Low Target $12.16

Average Target $16.27

High Target $21.27

Current Price $1.32

Current
$1.32

Target
$16.27

$12.16 $16.27 avg $21.27

Scenario Analysis

Bear Case

$12.16

821.2%

Low target

Base Case

$16.27

+1,132.6%

Avg target

Bull Case

$21.27

+1,511.4%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.07

-67.6% from high

52-Week Low

$0.81

+63.0% from low

Target vs 52W High

$16.27

+299.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%